Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, following the non-fulfillment of a profit guarantee by Jiumei Xinhe, which reported a net profit significantly below expectations for the year ending March 2024. The disposal, classified as a discloseable transaction, does not require shareholders’ approval under Hong Kong’s Listing Rules. This move reflects the company’s efforts to streamline operations and focus on more profitable ventures.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.